EZH2 and monoclonal gammopathy: EZH2 mRNA expression increases during progression from monoclonal gammopathy of undetermined significance (MGUS) through smoldering MM to overt MM [38, 39], and high EZH2 mRNA expression in newly-diagnosed MM patients associates with poor outcomes and high-risk clinical features [26].